Evidence map›Paper›PMID 42587775›Full record

ArticleCells2026

Macropinocytosis of Amyloid Precursor Protein Is Regulated by the Recruitment and Activity of Fe65, Arf6 and Rho GTPases.

Jordan M Krupa, Manoj Reddy Medapati, Abdul M Naqvi, Ryan D Hallam, Adrianna R Tsang, Claudia Seah, Shawn N Whitehead, Stephen H Pasternak

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jordan M KrupaNeuroscience Program, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON N6A 5B7, Canada.ORCID 0009-0004-8042-3851
Manoj Reddy MedapatiJ. Allyn Taylor Centre for Cell Biology, Molecular Medicine Research Group, Robarts Research Institute, 1151 Richmond St, London, ON N6A 5B8, Canada.ORCID 0000-0002-6342-5546
Abdul M NaqviNeuroscience Program, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON N6A 5B7, Canada.
Ryan D HallamJ. Allyn Taylor Centre for Cell Biology, Molecular Medicine Research Group, Robarts Research Institute, 1151 Richmond St, London, ON N6A 5B8, Canada.
Adrianna R TsangJ. Allyn Taylor Centre for Cell Biology, Molecular Medicine Research Group, Robarts Research Institute, 1151 Richmond St, London, ON N6A 5B8, Canada.
Claudia SeahJ. Allyn Taylor Centre for Cell Biology, Molecular Medicine Research Group, Robarts Research Institute, 1151 Richmond St, London, ON N6A 5B8, Canada.
Shawn N WhiteheadNeuroscience Program, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON N6A 5B7, Canada.
Stephen H PasternakNeuroscience Program, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON N6A 5B7, Canada.ORCID 0000-0002-0204-0255

Funding

Beaconbright Foundation N/A
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the buildup of aggregated amyloid-beta (Aβ) peptides. We previously demonstrated that Aβ is produced from APP following its lysosomal internalization via macropinocytosis. However, the regulation of APP macropinocytosis in neuronal cells remained uncharacterized. Arf6 and the Rho GTPases Rac1, Cdc42 and RhoA are known to regulate macropinocytosis in response to signaling at the cell surface. Fe65, an adaptor protein known to interact with APP, may link APP to these regulatory elements. We hypothesized that APP binding/crosslinking recruits Fe65, which recruits/activates Arf6 and then Rac1, Cdc42, and RhoA, driving APP macropinocytosis. We found that antibody-mediated binding/crosslinking APP resulted in the transient recruitment of Fe65 and Arf6 to APP within 30 s of APP binding/crosslinking. Rac1, Cdc42, and RhoA were also recruited at 30 s, but remained recruited through 2 min. The mutation of the APP 'YENPTY' sequence and Arf6 inhibition by NAV-2729 prevented the recruitment of Rac1, Cdc42, and RhoA. Together, these observations are the first to demonstrate that a network of regulatory proteins is recruited to bound/crosslinked APP and regulates its macropinocytosis. Targeting these regulatory proteins to modulate APP trafficking to the lysosome could be a therapeutic strategy to reduce Aβ production in AD.

Indexed as

ADP-Ribosylation FactorsAmyloid beta-Protein PrecursorNerve Tissue ProteinsPinocytosisrho GTP-Binding ProteinsADP-Ribosylation Factor 6Alzheimer DiseaseAnimalscdc42 GTP-Binding ProteinHumansNuclear ProteinsProtein BindingADP-Ribosylation Factor 6ADP-Ribosylation FactorsAmyloid beta-Protein PrecursorAPBB1 protein, humanARF6 protein, humancdc42 GTP-Binding ProteinNerve Tissue ProteinsNuclear Proteinsrho GTP-Binding ProteinsAlzheimer’s diseaseamyloid betaamyloid precursor proteinendocytosislysosomemacropinocytosisRho GTPase

Identifiers

PMID42587775
PMCPMC13464792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.